Adverse Drug Event Notification System Reusing clinical patient data for semi-automatic ADE detection

Date

2014-05-29

Author

Krahn, Tobias
Eichelberg, Marco
Gudenkauf, Stefan
Erturkmen, Gokce B. Laleci
Appelrath, H. -Juergen

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

347
views

0
downloads

Adverse drug events (ADEs) are common, costly and a public health issue. Today, their detection relies on medical chart review and spontaneous reports, but this is known to be rather ineffective. Along with the increasing availability of clinical patient data in electronic health records (EHRs), a computer-based ADE detection has a tremendous potential to contribute to patient safety. Current ADE detection systems are very specific, usually built directly on top of clinical information systems through proprietary interfaces. Thus, it is not possible to run different ADE detection tools on top of already existing systems in an ad-hoc manner. The European project "SALUS" aims at providing the necessary infrastructure and toolset for accessing and analyzing clinical patient data of heterogeneous clinical information systems. This paper highlights the SALUS ADE notification system as the key tool to enable a semi-automatic ADE detection and notification. In contrast to previous work, the ADE notification system is not restricted to a specific clinical environment. It can be run on different clinical data models with different levels of data quality. The system is equipped with innovative features, building up an intelligent, comprehensive ADE detection and notification system that promises a profound impact in the domain of computer-based ADE detection.

Subject Keywords

Adverse drug event (ADE), Adverse drug reaction (ADR), Linked open data, Electronic health record (EHR), Patient safety, Pharmacovigilance

URI

https://hdl.handle.net/11511/68039

Collections

Graduate School of Informatics, Software

Suggestions

OpenMETU
Core

Controlled release of bioactive agents in gene therapy and tissue engineering Keskin, DS; Hasırcı, Vasıf Nejat (2003-01-01) Even though the drugs are effective in the treatment of some diseases, they may be inefficient or incapable of solving the problem in some other diseases. It is known that some diseases have genetic causes and therefore the search for a therapy in these cases is intense. The solutions involving either direct application of a gene or its basic product, proteins, especially the growth factors, are oftencontemplated. Gene therapy is a novel approach to treating diseases based on modifying the expression of a p...
Surface functionalization of SBA - 15 particles for amoxicillin delivery Sevimli, Filiz F; Yılmaz, Ayşen; Department of Chemistry (2011) There are several studies in order to control drug delivery, decrease the toxicity of drugs and also for novel biomedical applications. It is necessary to be able to control the release of the drug within the body by using drug delivery systems. Mesoporous silica compounds have only been discovered twenty years ago and they have already attracted many researchers to study these materials for several applications. SBA-15 particles have a highly ordered regular structure and are a good matrix for guest-host a...
Understanding political priority development for public health issues in Turkey: lessons from tobacco control and road safety Hoe, Connie; Rodriguez, Daniela C.; Uzumcuoglu, Yesim; Hyder, Adnan A. (Springer Science and Business Media LLC, 2019-02-06) Tobacco use and road traffic injuries are major public health problems in Turkey. During the last decade, the former issue received political priority in the country, while the latter did not despite the immense health and economic burden that road traffic injuries pose on the Turkish population. Political priority can facilitate the attainment of public health goals. Unfortunately, however, limited cross-case analyses exist to help us understand why it emerges for certain public health issues but fails to ...
Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line Mutlu, Pelin; Gündüz, Ufuk (Elsevier BV, 2012-4) Drug resistance remains a major obstacle to the successful use of chemotherapeutic drugs for many types of cancers including multiple myeloma. It is becoming increasingly apparent that tumor microenvironment could provide a shelter to malignant plasma cells that allow their survival after initial drug exposure. This study demonstrates alterations in gene expression levels of several extracellular matrix (ECM) components in prednisone, vincristine and melphalan-resistant RPMI-8226 myeloma cells. Resistant RP...
INTEGRATIVE NETWORK MODELLING OF DRUG RESPONSES IN CANCER FOR REVEALING MECHANISM OF ACTION Ünsal Beyge, Şeyma; Tunçbağ, Nurcan; Department of Medical Informatics (2021-9-6) Classification of cancer drugs is crucial for drug repurposing since the cost and innovation deficit make new drug development processes challenging. Heterogeneity of cancer causes drug classification purely based on known mechanism of action (MoA) and the list of target proteins to be insufficient. Multi-omic data integration is necessary for a systems biology perspective to understand molecular mechanisms and interactions between cellular entities underlying the disease. This study integrates drug-target ...

Citation Formats